Hiroya Takeuchi and coworkers reported that c-MET copy numbers in primary CRC of N1/N2-stage patients were significantly higher than the copy numbers in N0 cases (P < 0.03) and that overexpression of c-MET mRNA in primary CRC may be a predictor of tumor invasion and lymph node metastases [32]. This evidence concerns the gene MET and neoplasm.